Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-24 @ 9:58 PM
Ignite Modification Date:
2025-12-25 @ 7:35 PM
NCT ID:
NCT02590432
Pre Assignment Details:
826 participants received LINZESS® 145μg \[CIC\] and 290μg \[IBS-C\] in the Open Label Treatment Period. Out of 826, 114 participants were randomized in the Double-blind Treatment Period and 57 out of 114 participants received 72 μg in the Dose-reduced Open Label Treatment Period due to intolerable AEs.
Recruitment Details:
828 participants were enrolled, 2 participants were enrolled but did not receive study treatment and were not included in any analysis populations.
Study:
NCT02590432
Study Brief:
Results Section:
NCT02590432